University of Pittsburgh logo

Paul Szabolcs, MD

  • Section Chief, Division of Pediatric Hematology Oncology and Stem Cell Transplantation

Administrative Assistant: Carla Clarke

Dr. Paul Szabolcs trained at Semmelweis University School of Medicine in Budapest. He completed his residency at Bellevue Hospital/NYU Medical Center and was Chief Fellow at Sloan Kettering Cancer Center in New York City. He completed postdoctoral fellowships at Memorial Sloan Kettering in Molecular Biology and at Rockefeller University in Physiology and Cellular Immunology. He has been the Division Director of Blood and Marrow Transplantation and Cellular Therapies since 2011.

Professional and Scientific Society Memberships

  • American Society of Hematology (ASH), 1995-Present
  • American Society for Blood and Marrow Transplantation (ASBMT), 1998-Present
  • American Association of Immunologists (AAI), 1998-Present
  • Fellow, American Academy of Pediatrics, 1998-Present
  • Center for International Blood and Marrow Transplant Research, 2004-Present
  • International Society for Cellular Therapy (ISCT), 2005-Present
  • Society for Pediatric Research (SPR), Member, 2006-Present
  • Center for International Blood and Marrow Transplant Research, 2009-2014
  • Clinical Immunology Society, 2010-Present
  • University of Pittsburgh Cancer Institute, 2012-Present
  • American Pediatric Society, 2013-Present
  • FOCIS, 2017-Present

Education & Training

  • MD, summa cum laude, Semmelweis University School of Medicine, 1985
  • Residency in Pediatrics, Bellevue Hospital-New York University Medical Center, 1987-1990
  • Research Assistant in Pediatrics, The Hospital of the University of Pennsylvania, 1986-1987
  • Teaching Assistant in Pediatrics, Bellevue Hospital-New York University Medical Center, 1989-1990
  • Fellowship in Pediatric Hematology-Oncology, Cornell University Medical College-New York Hospital, Memorial Sloan-Kettering Cancer Center, 1990-1993
  • Postdoctoral Fellowship, Memorial Sloan-Kettering Cancer Center, 1991-1993
  • Chief Fellow in Pediatric Hematology-Oncology, New York Hospital, Memorial Sloan-Kettering Cancer Center, 1992-1993
  • Special Fellow in Pediatrics, Memorial Sloan-Kettering Cancer Center, 1993-1994
  • Special Laboratory Training, Rockefeller University Department of Cellular Physiology and Immunology, 1994-1997
  • Special Laboratory Training, Duke University Medical Center, Division of Blood and Marrow Transplantation, Department of Pediatrics, 2008-2009

Selected Publications

Yoon IC, Bascou NA, Poe MD, Szabolcs P, Escolar ML. “Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease” Blood. 2021 April 1, 2021, 137(13): 1719-1730, PMID: 33150395

Dvorak CC, Haddad E, Heimall J, Dunn E, Cowan MJ, Pai SY, Kapoor N, Satter LF, Buckley RH, O'Reilly RJ, Chandra S, Bednarski JJ, Williams O, Rayes A, Moore TB, Ebens CL, Davila Saldana BJ, Petrovic A, Chellapandian D, Cuvelier GDE, Vander Lugt MT, Caywood EH, Chandrakasan S, Eissa H, Goldman FD, Shereck E, Aquino VM, Desantes KB, Madden LM, Miller HK, Yu L, Broglie L, Gillio A, Shah AJ, Knutsen AP, Andolina JP, Joshi AY, Szabolcs P, Kapadia M, Martinez CA, Parrot RE, Sullivan KE, Prockop SE, Abraham RS, Thakar MS, Leiding JW, Kohn DB, Pulsipher MA, Griffith LM, Notarangelo LD, Puck JM. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions. J Allergy Clin Immunol. 2022 Nov 28:S0091-6749(22)01478-6. PMID: 36456360

Leiding JW, Vogel TP, Santarlas VGJ, Mhaskar R, Smith MR, Carisey A, Vargas-Hernández A, Silva-Carmona M, Heeg M, Rensing-Ehl A, Neven B, Hadjadj J, Hambleton S, Ronan Leahy T, Meesilpavikai K, Cunningham-Rundles C, Dutmer CM, Sharapova SO, Taskinen M, Chua I, Hague R, Klemann C, Kostyuchenko L, Morio T, Thatayatikom A, Ozen A, Scherbina A, Bauer CS, Flanagan SE, Gambineri E, Giovannini-Chami L, Heimall J, Sullivan KE, Allenspach E, Romberg N, Deane SG, Prince BT, Rose MJ, Bohnsack J, Mousallem T, Jesudas R, Santos Vilela MMD, O'Sullivan M, Pachlopnik Schmid J, Průhová Š, Klocperk A, Rees M, Su H, Bahna S, Baris S, Bartnikas LM, Chang Berger A, Briggs TA, Brothers S, Bundy V, Chan AY, Chandrakasan S, Christiansen M, Cole T, Cook MC, Desai MM, Fischer U, Fulcher DA, Gallo S, Gauthier A, Gennery AR, Gonçalo Marques J, Gottrand F, Grimbacher B, Grunebaum E, Haapaniemi E, Hämäläinen S, Heiskanen K, Heiskanen-Kosma T, Hoffman HM, Gonzalez-Granado LI, Guerrerio AL, Kainulainen L, Kumar A, Lawrence MG, Levin C, Martelius T, Neth O, Olbrich P, Palma A, Patel NC, Pozos T, Preece K, Lugo Reyes SO, Russell MA, Schejter Y, Seroogy C, Sinclair J, Skevofilax E, Suan D, Suegeorgz D, Szabolcs P, Velasco H, Warnatz K, Walkovich K, Worth A; STAT3 GOF Working Group members; Seppänen MRJ, Torgerson TR, Sogkas G, Ehl S, Tangye SG, Cooper MA, Milner JD, Forbes Satter LR. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome. J Allergy Clin Immunol. 2023 Oct 11:S0091-6749(22)01182-PMID: 36228738

Dvorak CC, Haddad E, Heimall J, Dunn E, Cowan MJ, Pai SY, Kapoor N, Satter LF, Buckley RH, O'Reilly RJ, Chandra S, Bednarski JJ, Williams O, Rayes A, Moore TB, Ebens CL, Davila Saldana BJ, Petrovic A, Chellapandian D, Cuvelier GDE, Vander Lugt MT, Caywood EH, Chandrakasan S, Eissa H, Goldman FD, Shereck E, Aquino VM, Desantes KB, Madden LM, Miller HK, Yu L, Broglie L, Gillio A, Shah AJ, Knutsen AP, Andolina JP, Joshi AY, Szabolcs P, Kapadia M, Martinez CA, Parrot RE, Sullivan KE, Prockop SE, Abraham RS, Thakar MS, Leiding JW, Kohn DB, Pulsipher MA, Griffith LM, Notarangelo LD, Puck JM. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions. J Allergy Clin Immunol. 2023 Feb;151(2):547-555.e5. PMID: 36456360

Szabolcs P, Mazor RD, Yackoubov D, Levy S, Stiff P, Rezvani A, Hanna R, Wagner J, Keating A, Lindemans CA, Karras N, McGuirk J, Hamerschlak N, López I, Sanz G, Valcarcel D, Horwitz. Immune Reconstitution Profiling Suggests Antiviral Protection After Transplantation with Omidubicel: a Phase 3 Substudy. Transplant Cell Ther. 2023 Aug;29(8):517, PMID: 37120136.

Mike Winstead, Memphis Hill, Zarreen Amin, Mark Vander Lugt , Xiaohua Chen, Paul Szabolcs. Graftversus-host disease is associated with skewed γδ T-cell clonality after umbilical cord blood transplantation in children with nonmalignant diseases., Cytotherapy, July 8, 2023, PMID 37422745

Allison M. Bradbury, Jessica Bagel, Gary Swain, Keiko Miyadera, Jill P. Pesayco, Charles-Antoine Assenmacher, Becky Brisson, Ian Hendricks, Xiao H. Wang, Zachary Herbst, Nettie Pyne, Patricia Odonnell, G. Diane Shelton, Michael Gelb, Neil Hackett, Paul Szabolcs, Charles H. Vite, Maria Escolar, Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy, Molecular Therapy, 2024, Volume 32, Issue 1, Pages 44-58, PMID: 37952085; PMCID: PMC10787152.

Merli P, Jodele S, Cook E, Myers KC, Lane A, Ryhänen S, Cefalo MP, Quagliarella F, Davies SM, Teusink-Cross A, Aguayo-Hiraldo P, Alexander JL, Szabolcs P, Kohorst M, Corsetti T, Locatelli F, Sabulski A. Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT. Bone Marrow Transplant. 2025 Mar;60(3):406-411. doi: 10.1038/s41409-024-02487-w. Epub 2024 Dec 3. PMID:39627345.

Hadjiyannis Y, Bubar R, Triulzi DJ, Kiss J, Marino CC, Windreich RM, Szabolcs P, Kaplan A. Prophylactic high-dose granulocyte transfusions following allogeneic haematopoietic stem cell transplantation. Vox Sang. 2025 May 14. doi: 10.1111/vox.70044. Epub ahead of print. PMID: 40368633.

Perales MA, Riches M, He N, Martens MJ, Chemaly RF, Dandoy CE, Hill JA, Díaz MA, Hashmi S, Prockop SE, Lazarus HM, Beitinjaneh AM, Hildebrandt GC, Auletta JJ, Szabolcs P. Delayed T cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults. Blood Adv. 2025 Apr 18:bloodadvances.2024015288. doi: 10.1182/bloodadvances.2024015288. Epub ahead of print. PMID: 40249911.

Full Publication List via NIH PubMed »